Vogel J, Görich J, von Ahlen H, Harder T, Friedrich J M, Rilinger N, Merkle E, Brambs H J
Universitätsklinik Ulm, Radiologische Klinik.
Aktuelle Radiol. 1995 Sep;5(5):301-4.
We pointed out the value of catheter embolisation of kidney tumours.
We treated 42 patients with kidney tumours. For peripheral embolisation we placed Histoacryl or Ethibloc into the kidney artery via a transfemoral catheter. 33 patients had haematuria. 8 patients were lost for follow up. 26 patients were treated by embolisation alone and 8 patients were treated before nephrectomy.
Haematuria was stopped in 98% and never reoccurred. The intraoperative blood-loss was 600 ml on average. 55% of patients treated by embolisation alone died within the first year. 51% of patients suffered from a slight postinfarction syndrome. One patient died of sepsis and one had pulmonary insufficiency due to AV shunt and pulmonary embolism.
Peripheral embolisation of kidney tumours can be used successfully and is minimal invasive, in case of haematuria and pain. The perioperative risk is reduced due to limited blood loss.
我们指出了肾肿瘤导管栓塞术的价值。
我们治疗了42例肾肿瘤患者。对于外周栓塞，我们通过经股动脉导管将组织黏合剂或乙碘油注入肾动脉。33例患者有血尿。8例患者失访。26例患者仅接受栓塞治疗，8例患者在肾切除术前接受治疗。
98%的血尿停止且未再复发。术中平均失血量为600毫升。仅接受栓塞治疗的患者中有55%在第一年内死亡。51%的患者患有轻度梗死后期综合征。1例患者死于败血症，1例因动静脉分流和肺栓塞导致肺功能不全。
肾肿瘤外周栓塞术可成功应用且微创，适用于血尿和疼痛情况。由于失血有限，围手术期风险降低。
